sodium salicylate has been researched along with bosentan anhydrous in 1 studies
| Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (bosentan anhydrous) | Trials (bosentan anhydrous) | Recent Studies (post-2010) (bosentan anhydrous) |
|---|---|---|---|---|---|
| 2,031 | 50 | 171 | 1,836 | 215 | 630 |
| Protein | Taxonomy | sodium salicylate (IC50) | bosentan anhydrous (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Rattus norvegicus (Norway rat) | 0.095 | |
| Endothelin receptor type B | Homo sapiens (human) | 0.3044 | |
| Endothelin-1 receptor | Homo sapiens (human) | 0.2317 | |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | 0.0047 | |
| Endothelin-1 receptor | Sus scrofa (pig) | 0.0075 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berkane, N; Blandin, V; Breittmayer, JP; Ferrari, E; Frelin, C; Talbodec, A; Vigne, P | 1 |
1 other study(ies) available for sodium salicylate and bosentan anhydrous
| Article | Year |
|---|---|
Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism.
Topics: Allosteric Regulation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Aspirin; Biological Transport; Bosentan; Calcium; Cells, Cultured; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Humans; Mammary Arteries; Muscle Contraction; Rats; Receptors, Endothelin; Sodium Salicylate; Sulfonamides | 2000 |